Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Upsala Journal of Medical Sciences
|
February 22, 2012
Myc proteins in brain tumor development and maintenance
Fredrik J Swartling
Molecular & Cellular Oncology
|
February 16, 2017
Targeting SOX9 for degradation to inhibit chemoresistance, metastatic spread, and recurrence
Aldwin Suryo Rahmanto, Fredrik J Swartling, Olle Sangfelt
Acta Neuropathologica
|
July 21, 2017
Medulloblastoma: experimental models and reality
Julia E Neumann, Fredrik J Swartling, Ulrich Schüller
Cancer Metastasis Reviews
|
October 23, 2012
What underlies the diversity of brain tumors?
Fredrik J Swartling, Sanna-Maria Hede, William A Weiss
Genes
|
March 24, 2017
Modeling and Targeting MYC Genes in Childhood Brain Tumors
Sonja Hutter, Sara Bolin, Holger Weishaupt, et al.
Frontiers in Oncology
|
February 15, 2021
Targeting MYCN in Molecularly Defined Malignant Brain Tumors
Anna Borgenvik, Matko Čančer, Sonja Hutter, et al.
Experimental Neurology
|
February 5, 2013
Signals that regulate the oncogenic fate of neural stem cells and progenitors
Fredrik J Swartling, Sara Bolin, Joanna J Phillips, et al.
Cell and Tissue Research
|
November 23, 2014
Deregulated proliferation and differentiation in brain tumors
Fredrik J Swartling, Matko Čančer, Aaron Frantz, et al.
Cancers
|
May 11, 2024
Drivers Underlying Metastasis and Relapse in Medulloblastoma and Targeting Strategies
Karl O Holmberg, Anna Borgenvik, Miao Zhao, et al.
RSC Advances
|
June 15, 2022
Photophysical characterization and fluorescence cell imaging applications of 4-<i>N</i>-substituted benzothiadiazoles
Susanne Doloczki, Karl O Holmberg, Ignacio Fdez Galván, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Upsala Journal of Medical Sciences
|
February 22, 2012
Myc proteins in brain tumor development and maintenance
Fredrik J Swartling
Molecular & Cellular Oncology
|
February 16, 2017
Targeting SOX9 for degradation to inhibit chemoresistance, metastatic spread, and recurrence
Aldwin Suryo Rahmanto, Fredrik J Swartling, Olle Sangfelt
Acta Neuropathologica
|
July 21, 2017
Medulloblastoma: experimental models and reality
Julia E Neumann, Fredrik J Swartling, Ulrich Schüller
Cancer Metastasis Reviews
|
October 23, 2012
What underlies the diversity of brain tumors?
Fredrik J Swartling, Sanna-Maria Hede, William A Weiss
Genes
|
March 24, 2017
Modeling and Targeting MYC Genes in Childhood Brain Tumors
Sonja Hutter, Sara Bolin, Holger Weishaupt, et al.
Frontiers in Oncology
|
February 15, 2021
Targeting MYCN in Molecularly Defined Malignant Brain Tumors
Anna Borgenvik, Matko Čančer, Sonja Hutter, et al.
Experimental Neurology
|
February 5, 2013
Signals that regulate the oncogenic fate of neural stem cells and progenitors
Fredrik J Swartling, Sara Bolin, Joanna J Phillips, et al.
Cell and Tissue Research
|
November 23, 2014
Deregulated proliferation and differentiation in brain tumors
Fredrik J Swartling, Matko Čančer, Aaron Frantz, et al.
Cancers
|
May 11, 2024
Drivers Underlying Metastasis and Relapse in Medulloblastoma and Targeting Strategies
Karl O Holmberg, Anna Borgenvik, Miao Zhao, et al.
RSC Advances
|
June 15, 2022
Photophysical characterization and fluorescence cell imaging applications of 4-<i>N</i>-substituted benzothiadiazoles
Susanne Doloczki, Karl O Holmberg, Ignacio Fdez Galván, et al.
Page
of 6